Skip to search formSkip to main contentSkip to account menu

Diphereline

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Comparing The Effects of Glycyrrhiza glabra Root Extract, A Cyclooxygenase-2 Inhibitor (Celecoxib) and A Gonadotropin-Releasing Hormone Analog (Diphereline) In A Rat Model of Endometriosis
Background The purpose of this study was to compare the effects of Glycyrrhiza glabra (Licorice), a cyclooxyge- nase-2 inhibitor… 
2016
2016
Benign Metastasizing Leiomyomas of the Lungs: A Case Report
Background: Benign metastasizing leiomyoma (BML) is a very rare condition, which is paradoxically called benign metastases and… 
Review
2015
Review
2015
Comparison of the post-operative infection by using different type of prophylactic antibiotics and placebo in healthy adult patients who underwent ureterorenoscopic surgery
2015
2015
Comparison of the Efficacy of Two Brands of Triptorelin (Microrelin and Diphereline) in Reducing Prostate-Specific Antigen and Serum Testosterone in Prostate Cancer: A Double-Blinded Randomized…
Background: Gonadotropin-releasing hormone (GnRH) agonists initiate androgen deprivation in treating prostate cancer (PC… 
2014
2014
Self‐control study on reduced‐dose depot versus daily administration of gonadotrophin‐releasing hormone agonists for pituitary desensitization in in vitro fertilization cycles
Our aim was to analyze the effect of reducing the dose of depot gonadotrophin‐regulating hormone‐agonist (GnRH‐a) to 1.0 mg on… 
2014
2014
Evaluation of the effect of GnRH agonist on menstrual reverse in breast cancer cases treated with cyclophosphamide.
UNLABELLED Twenty-five percent of breast cancer cases are detected during premenopausal period and the number of young women… 
2013
2013
The side effects of gonadotropin releasing hormone analog (diphereline) in treatment of idiopathic central precocious puberty.
Treatment of central precocious puberty (CPP) is the administration of GnRH analogs. Metabolic syndrome comprised metabolic… 
2010
2010
Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
Introduction The aim of the study was to compare the efficacy of half-dose, long-acting GnRH analogue (Diphereline) with… 
2009
2009
Comparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changes.
OBJECTIVE To investigate the effect of 2 medications; Diphereline and Cabergoline, on uterine leiomyoma growth, and its… 
2007
2007
Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
OBJECTIVE To investigate the effect of cabergoline (Dostinex, a dopamine agonist) on the myoma growth compared to Diphereline (a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)